Literature DB >> 22230333

Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods.

Stefania Stefani1, Doo Ryeon Chung, Jodi A Lindsay, Alex W Friedrich, Angela M Kearns, Henrik Westh, Fiona M Mackenzie.   

Abstract

This article reviews recent findings on the global epidemiology of healthcare-acquired/associated (HA), community-acquired/associated (CA) and livestock-associated (LA) meticillin-resistant Staphylococcus aureus (MRSA) and aims to reach a consensus regarding the harmonisation of typing methods for MRSA. MRSA rates continue to increase rapidly in many regions and there is a dynamic spread of strains across the globe. HA-MRSA is currently endemic in hospitals in most regions. CA-MRSA clones have been spreading rapidly in the community and also infiltrating healthcare in many regions worldwide. To date, LA-MRSA is only prevalent in certain high-risk groups of workers in direct contact with live animals. CA-MRSA and LA-MRSA have become a challenge for countries that have so far maintained low rates of MRSA. These evolutionary changes have resulted in MRSA continuing to be a major threat to public health. Continuous efforts to understand the changing epidemiology of S. aureus infection in humans and animals are therefore necessary, not only for appropriate antimicrobial treatment and effective infection control but also to monitor the evolution of the species. The group made several consensus decisions with regard to harmonisation of typing methods. A stratified, three-level organisation of testing laboratories was proposed: local; regional; and national. The functions of, and testing methodology used by, each laboratory were defined. The group consensus was to recommend spa and staphylococcal cassette chromosome mec (SCCmec) typing as the preferred methods. Both are informative in defining particular strain characteristics and utilise standardised nomenclatures, making them applicable globally. Effective communication between each of the different levels and between national centres was viewed as being crucial to inform and monitor the molecular epidemiology of MRSA at national and international levels. Copyright Â
© 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22230333     DOI: 10.1016/j.ijantimicag.2011.09.030

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  148 in total

1.  Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus.

Authors:  Lidia Kardas-Sloma; Pierre-Yves Boëlle; Lulla Opatowski; Didier Guillemot; Laura Temime
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

2.  National surveillance of methicillin-resistant Staphylococcus aureus in China highlights a still-evolving epidemiology with 15 novel emerging multilocus sequence types.

Authors:  Meng Xiao; He Wang; Ying Zhao; Lei-Li Mao; Mitchell Brown; Yun-Song Yu; Matthew V N O'Sullivan; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

3.  Using Quantitative Spectrometry to Understand the Influence of Genetics and Nutritional Perturbations On the Virulence Potential of Staphylococcus aureus.

Authors:  Jessica R Chapman; Divya Balasubramanian; Kayan Tam; Manor Askenazi; Richard Copin; Bo Shopsin; Victor J Torres; Beatrix M Ueberheide
Journal:  Mol Cell Proteomics       Date:  2017-02-14       Impact factor: 5.911

Review 4.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

Review 5.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

Review 6.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

7.  Salvage surgery for head and neck squamous cell carcinoma.

Authors:  Magis Mandapathil; Marion Roessler; Jochen A Werner; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

8.  Companies Take Aim at MRSA Infections.

Authors:  Chris Fellner
Journal:  P T       Date:  2016-02

9.  Roles of lytic transglycosylases in biofilm formation and β-lactam resistance in methicillin-resistant Staphylococcus aureus.

Authors:  Anne-Aurelie Lopes; Yutaka Yoshii; Satomi Yamada; Mari Nagakura; Yuki Kinjo; Yoshimitsu Mizunoe; Ken-Ichi Okuda
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

10.  Genotypic characterization of methicillin-resistant Staphylococcus aureus strains isolated from the anterior nares and catheter of ambulatory hemodialysis patients in Mexico.

Authors:  Gloria Paniagua-Contreras; Eric Monroy-Pérez; Raúl Gutiérrez-Lucas; Teresita Sainz-Espuñes; Jaime Bustos-Martínez; Sergio Vaca
Journal:  Folia Microbiol (Praha)       Date:  2014-01-15       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.